Search Startups
Tagged as ('autoimmune-diseases') Startups
Filters
Clear
39 Startups
6 In the News
6 Recently Updated
-
Total Funding$1.19BRaised68Events
-
Private Funding$626.15MRaised35Rounds
-
Public Offerings$561.95MRaised31Offerings
-
M&A$0Raised2Deals
Funding
Rounds / Deals
Tags
CytoReason
Immunai
Predicta Med
Gamida Cell
Public
BiomX
Public
Enlivex Therapeutics R&D
Public
OBCTCD24
Presumed Inactive
?
Based on data collected from different sources by our team,
there are indicators that suggest that this company is no longer active. However, this information may not be accurate.
If you believe this information should be updated, please .
For more details, you can read our .
Search Startups
-
Total Funding$1.19BRaised68Events
-
Private Funding$626.15MRaised35Rounds
-
Public Offerings$561.95MRaised31Offerings
-
M&A$0Raised2Deals
Funding
Rounds / Deals
Raised
$52M
CytoReason
Machine Learning for Data-driven Target Discovery and Drug Development
Founded:2016
Business Model:B2B
Employees:51-200
Funding Stage:A
Raised
$295M
Immunai
Peripheral Tissue Analysis
Founded:2019
Business Model:B2B
Employees:1-10
Funding Stage:B
Raised
$2.2M
Predicta Med
Decision-support Platform for Early Detection and Intervention Selection of Autoimmune Diseases
Founded:2020
Business Model:B2B
Employees:11-50
Funding Stage:Seed
Raised
$310.02M
Gamida Cell
Public
Cellular and Immune Therapies
Founded:1998
Business Model:B2B
Employees:51-200
Funding Stage:Public
Raised
$81.5M
BiomX
Public
Microbiome Therapies for Chronic Diseases
Founded:2015
Business Model:B2B
Employees:51-200
Funding Stage:Public
Raised
$72.2M
Enlivex Therapeutics R&D
Public
Macrophage Reprogramming Cell Therapies for Life-threatening Diseases
Founded:2005
Business Model:B2B
Employees:11-50
Funding Stage:Public
Raised
Undisclosed
OBCTCD24
Presumed Inactive
?
Based on data collected from different sources by our team,
there are indicators that suggest that this company is no longer active. However, this information may not be accurate.
If you believe this information should be updated, please .
For more details, you can read our .
Exosome-delivered CD24-based Therapeutics
Founded:2020
Business Model:B2B
Employees:1-10
Funding Stage:Pre-Funding
Unlock financial data
Finder is provided for free by the non-profit organization Start-Up Nation Central.
- Get unlimited search results
- Save to custom lists - Watchlists
- Get notified with news and updates
- Connect with people
And much more...
I already have access,